Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (838)
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
401
Price
$553.99
Total Value
$222.15K
Shares Held After
28,435
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$551.86
Total Value
$22.07K
Shares Held After
28,836
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$571.66
Total Value
$68.60K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$570.05
Total Value
$45.60K
Shares Held After
40,633
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$568.53
Total Value
$68.22K
Shares Held After
40,713
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
308
Price
$567.70
Total Value
$174.85K
Shares Held After
40,833
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
570
Price
$566.39
Total Value
$322.84K
Shares Held After
41,141
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
811
Price
$565.38
Total Value
$458.52K
Shares Held After
41,711
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,918
Price
$564.55
Total Value
$1.08M
Shares Held After
42,522
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
865
Price
$563.52
Total Value
$487.45K
Shares Held After
44,440
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
378
Price
$562.49
Total Value
$212.62K
Shares Held After
45,305
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
570
Price
$561.60
Total Value
$320.11K
Shares Held After
45,683
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$559.98
Total Value
$22.40K
Shares Held After
46,253
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$558.51
Total Value
$245.74K
Shares Held After
46,293
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$557.40
Total Value
$434.77K
Shares Held After
46,733
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
808
Price
$556.52
Total Value
$449.67K
Shares Held After
47,513
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,058
Price
$555.41
Total Value
$587.62K
Shares Held After
48,321
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
394
Price
$554.45
Total Value
$218.46K
Shares Held After
49,379
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
175
Price
$553.50
Total Value
$96.86K
Shares Held After
49,773
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
65
Price
$552.25
Total Value
$35.90K
Shares Held After
49,948
% of Holdings
0.1%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Milanova Tsveta — Chief Commercial Officer
Shares
3,262
Price
$34.71
Total Value
$113.22K
Shares Held After
46,829
% of Holdings
6.5%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
3,472
Price
$35.00
Total Value
$121.52K
Shares Held After
75,556
% of Holdings
4.4%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Goff Brian — Director
Shares
6,596
Price
$34.71
Total Value
$228.95K
Shares Held After
184,508
% of Holdings
3.5%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Goff Brian — Director
Shares
12,472
Price
$34.71
Total Value
$432.90K
Shares Held After
177,604
% of Holdings
6.6%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Viswanadhan Krishnan — Chief Corp Dev & Strategy
Shares
2,959
Price
$34.71
Total Value
$102.71K
Shares Held After
10,282
% of Holdings
22.3%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Jones Cecilia — Chief Financial Officer
Shares
3,141
Price
$34.71
Total Value
$109.02K
Shares Held After
54,998
% of Holdings
5.4%
Immunome Inc. (IMNM)
Rosett Max — Chief Financial Officer
Shares
1,344
Price
$22.48
Total Value
$30.21K
Shares Held After
54,037
% of Holdings
2.4%
Immunome Inc. (IMNM)
Rosett Max — Chief Financial Officer
Shares
63,656
Price
$21.91
Total Value
$1.39M
Shares Held After
55,381
% of Holdings
53.5%
Immunome Inc. (IMNM)
Higgins Jack — Chief Scientific Officer
Shares
9,438
Price
$21.64
Total Value
$204.24K
Shares Held After
22,000
% of Holdings
30.0%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
26,858
Price
$3.48
Total Value
$93.47K
Shares Held After
793,549
% of Holdings
3.3%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
5,576
Price
$20.39
Total Value
$113.69K
Shares Held After
1,125,279
% of Holdings
0.5%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
5,199
Price
$20.39
Total Value
$106.01K
Shares Held After
32,558
% of Holdings
13.8%
Zai Lab Ltd (ZLAB)
Smiley Joshua L — President and Chief Operating Officer
Shares
9,614
Price
$20.39
Total Value
$196.03K
Shares Held After
120,619
% of Holdings
7.4%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
9,910
Price
$20.39
Total Value
$202.06K
Shares Held After
59,761
% of Holdings
14.2%
Voyager Therapeutics, Inc. (VYGR)
Sandrock Alfred — Director
Shares
11,511
Price
$3.87
Total Value
$44.55K
Shares Held After
472,549
% of Holdings
2.4%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
4,194
Price
$20.39
Total Value
$85.52K
Shares Held After
24,590
% of Holdings
14.6%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Sabar Karimah Es — Director
Shares
7,529
Price
$32.00
Total Value
$240.93K
Shares Held After
0
% of Holdings
100.0%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
713,800
Price
$2.10
Total Value
$1.50M
Shares Held After
3,288,539
% of Holdings
21.7%
Immunovant, Inc. (IMVT)
Venker Eric — Director
Shares
1,409
Price
$24.60
Total Value
$34.66K
Shares Held After
19,561
% of Holdings
6.7%
Immunovant, Inc. (IMVT)
Venker Eric — Director
Shares
12,820
Price
$24.04
Total Value
$308.19K
Shares Held After
20,970
% of Holdings
37.9%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
1,780
Price
$17.57
Total Value
$31.27K
Shares Held After
17,338
% of Holdings
9.3%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
6,200
Price
$17.02
Total Value
$105.55K
Shares Held After
19,118
% of Holdings
24.5%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
2,529,491
Price
$3.28
Total Value
$8.29M
Shares Held After
10,265,297
% of Holdings
19.8%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
2,634,506
Price
$3.28
Total Value
$8.64M
Shares Held After
12,666,731
% of Holdings
17.2%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
600
Price
$41.77
Total Value
$25.06K
Shares Held After
183,316
% of Holdings
0.3%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
4,231
Price
$40.88
Total Value
$172.96K
Shares Held After
183,916
% of Holdings
2.2%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
12,477
Price
$40.29
Total Value
$502.70K
Shares Held After
188,147
% of Holdings
6.2%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
12,692
Price
$39.14
Total Value
$496.76K
Shares Held After
200,624
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$571.61
Total Value
$114.32K
Shares Held After
45,172
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
710
Price
$569.61
Total Value
$404.42K
Shares Held After
45,372
% of Holdings
1.5%
Showing 151–200 of 838 transactions (page 4 of 17)